Skip to main content

Biotechnology Startups

Updated October 2026

Companies in the biotechnology sector developing innovative solutions and technologies.

Explore 5,823 recently funded biotechnology companies with verified founder contact information and fundraising data.

Total Companies
5,823
Total Funding
$834.9M
Avg Funding
$33.4M
Global Reach
7
countries

Top Cities for Biotechnology

Fort Collins
South San Francisco
Calabasas
Orange
Bozeman
New York

Recently Funded Companies

Export
Fort Collins, United States

Axiota Animal Health develops and markets products for beef and dairy producers, including MultiMin 90 and Lactipro.

$30.1M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Nkarta Therapeutics is a developer of cell engineering platform created to build the next generation of cell therapies.

$240.0M raised
Mar 2024

Founder Contacts

41,000+ verified contacts

Calabasas, United States

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

$7.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Orange, Australia

Cauldron Ferm is a bio-acceleration process that exponentially scales up any precision fermented prototype to commercial quantities.

$13.3M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Bozeman, United States

ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.

Mar 2026

Founder Contacts

41,000+ verified contacts

New York, United States

Gilgamesh Pharmaceuticals is a clinical-stage biotechnology company that develops psychedelic and related drugs to treat mental illnesses.

$60.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

$5.8M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

Origin is a biotech company that creates patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies.

Mar 2026

Founder Contacts

41,000+ verified contacts

Lund, Sweden

Hamlet BioPharma is a pharmaceutical company with strong links to research.

$967K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United Kingdom

Immutrin is a biotech developing next‑generation antibody therapies to clear amyloid deposits and reverse amyloidosis.

$87.1M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

San Diego, United States

Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.

$400K raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Aptadel Therapeutics is a pre-clinical biomedical company.

$2.3M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Leiden, The Netherlands

EXIT071 is a Netherlands-based startup developing advanced technologies for extracellular vesicle (EV) isolation and analysis.

$2.1M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Leuven, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

$83.9M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

$175.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Birmingham, United States

CirculoGene specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics.

$2.0M raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Columbia, United States

Nexgen Forensic Sciences is a biotechnology company currently operating in stealth mode.

$450K raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Princeton, United States

Santiste Medical is a biotechnology company currently operating in stealth mode.

$89K raised
Mar 2023

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

$83.0M raised
Mar 2022

Founder Contacts

41,000+ verified contacts

Girona, Spain

We strengthen the biopharmaceutical sector, biotech startups, and scientific communities with our biotechnological solutions.

$2.8M raised
Mar 2022

Founder Contacts

41,000+ verified contacts

Belmont, United States

Oryon Cell treatments is a clinical-stage biotechnology business exploring autologous cell treatments for neurodegenerative illnesses.

$21.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

San Francisco, United States

ImmuneBridge is developing allogeneic immunotherapies for cancer.

$7.7M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Tessera Therapeutics develops gene writing technology designed to modify DNA sequences within human cells for therapeutic use.

Mar 2026

Founder Contacts

41,000+ verified contacts

Lewes, United States

Halcyon Wellness is a biotechnology company that offers bioengineered liver health and wellness services.

$8.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Jupiter, United States

Myosin Therapeutics is a privately-held biopharmaceutical company developing novel medications for CNS-based disorders.

$2.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Showing 2626 to 2650 of 5,823 companies

About the Biotechnology Startup Ecosystem

The biotechnology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biotechnology

Biotechnology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biotechnology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biotechnology Funding Breakdown

Here is how funding is distributed among the 5,823 biotechnology companies tracked in the VCBacked database.

Average Funding
$33.4M
Total Funding Tracked
$834.9M
Countries Represented
7

Distribution by Funding Stage

Other25 companies

Top Cities for Biotechnology

1.Cambridge
3 companies$170.1M
2.South San Francisco
2 companies$415.0M
3.Barcelona
2 companies$8.1M
4.San Francisco
2 companies$7.7M
5.Fort Collins
1 companies$30.1M

Related Industries

Companies in the biotechnology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biotechnology Startups?

Perfect for: B2B sales teams targeting biotechnology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

5,823 Biotechnology Startups (2026) — Recently Funded — Page 106 | VCBacked